Rosemary Gibson, a senior advisor at the Hastings Center and researcher and lecturer of public health and policy has a grim warning for America: China is trying to dominate national healthcare. Per Fox Business, the author has recently come out with a book, China Rx, which details the consequences of a Chinese monopoly on medicine.
“China’s aim is to disrupt, to dominate and displace American companies and harm our ability to make our own medicines.”
“We are losing control over the supply of our medicines, and that’s not an exaggeration,” Gibson said. “And when we lose control, we lose control over price.”
Another frightening aspect of Chinese growth in the medicine field is the lack of quality control. Gibson gave an example where there was a massive recall of Chinese blood pressure medication due to the presence of excess carcinogens. When tested, the pills contained a staggering 200 times the acceptable level.
0 comments :
Post a Comment